What does atypical fibroadenoma mean?

The phrase is not a complete diagnosis on its own. Depending on the report, atypical may describe the lump's appearance on imaging, unusual cells in a tissue sample, or features that overlap with another fibroepithelial breast lesion.

Fibroadenomas are made of glandular and supporting breast tissue. A radiologist assesses shape, margins and internal appearance, while a pathologist assesses sampled tissue. The next recommendation depends on whether the examination, imaging and pathology findings agree.

Atypical does not automatically mean breast cancer. It does signal that the report needs a precise explanation, particularly whether cellular atypia was found, whether the sample represents the whole area, and whether another type of fibroepithelial lesion must be excluded.

Obtain the exact imaging and pathology wording rather than relying on the word atypical alone. Your breast specialist may compare prior scans, arrange targeted ultrasound, request a core biopsy, review the tissue with a breast pathologist or discuss removing the lump.

Management can range from planned imaging follow-up to surgical excision. The choice reflects the lesion's growth, size, symptoms, sampling result, agreement between tests and your preferences. Attend the recommended follow-up even if the lump feels unchanged.

Contact your breast clinic if the lump enlarges noticeably, becomes persistently painful, or the skin or nipple changes. New nipple inversion, spontaneous bloody discharge, skin dimpling, marked redness or a new armpit lump also need clinical assessment.

Seek urgent care for rapidly spreading breast redness with fever or feeling acutely unwell, especially after a biopsy or operation. After a procedure, report heavy bleeding, an expanding swelling, worsening pain or discharge from the wound using the clinic's aftercare number.

Ask which specific feature was called atypical, whether imaging and pathology are concordant, and whether the sample was adequate. Clarify the recommended follow-up interval, what change would lead to another biopsy or excision, and who will review the final pathology if the lump is removed.